VANI Vivani Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: VANI

Price (delayed)

$0.95

Market cap

$48.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.56

Enterprise value

$43.34M

Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in ...

Highlights
Vivani Medical's net income has shrunk by 163% YoY and by 44% QoQ
The EPS has dropped by 93% year-on-year and by 44% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Peers: PDEX OFIX NVRO

Key stats

What are the main financial stats of VANI
Market
Shares outstanding
51.03M
Market cap
$48.47M
Enterprise value
$43.34M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.84
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$26.91M
EBITDA
-$25.77M
Free cash flow
-$25.65M
Per share
EPS
-$0.56
Free cash flow per share
-$0.5
Book value per share
$0.52
Revenue per share
$0
TBVPS
$1.05
Balance sheet
Total assets
$53.32M
Total liabilities
$27.11M
Debt
$21.06M
Equity
$26.21M
Working capital
$23.25M
Liquidity
Debt to equity
0.8
Current ratio
4.13
Quick ratio
3.52
Net debt/EBITDA
0.2
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-51.6%
Return on equity
-76.2%
Return on invested capital
-134.9%
Return on capital employed
-58.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VANI stock price

How has the Vivani Medical stock price performed over time
Intraday
0%
1 week
-0.5%
1 month
-12.04%
1 year
-32.14%
YTD
11.8%
QTD
-6.86%

Financial performance

How have Vivani Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$28.54M
Net income
-$26.91M
Gross margin
N/A
Net margin
N/A
Vivani Medical's net income has shrunk by 163% YoY and by 44% QoQ
VANI's operating income has shrunk by 68% YoY and by 6% QoQ

Growth

What is Vivani Medical's growth rate over time

Valuation

What is Vivani Medical stock price valuation
P/E
N/A
P/B
1.84
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 93% year-on-year and by 44% since the previous quarter
VANI's price to book (P/B) is 77% less than its 5-year quarterly average of 8.0 but 23% more than its last 4 quarters average of 1.5
The equity has contracted by 49% YoY and by 19% from the previous quarter

Efficiency

How efficient is Vivani Medical business performance
The return on assets has dropped by 148% year-on-year and by 47% since the previous quarter
The return on equity has dropped by 69% since the previous quarter
Vivani Medical's return on invested capital has increased by 42% YoY and by 28% QoQ

Dividends

What is VANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VANI.

Financial health

How did Vivani Medical financials performed over time
The total assets is 97% more than the total liabilities
The company's quick ratio has shrunk by 62% YoY and by 26% QoQ
Vivani Medical's current ratio has shrunk by 57% YoY and by 19% QoQ
The debt is 20% lower than the equity
The equity has contracted by 49% YoY and by 19% from the previous quarter
VANI's debt to equity is up by 23% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.